Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Explore various work from home opportunities that can help you earn extra cash. Take advantage of these options to boost your income.
22,767 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A year retiree with only $400K is turning to a two-ETF income strategy to secure roughly $2,500 per month, blending e...
A Berkshire-inspired ETF touts a 15% yield by layering a stock-picker approach with an option strategy and return of ...
A low-priced stock can spark big gains, but it requires solid research and a disciplined plan. This guide breaks down...
February delivered a surprising 10% rise for Sandisk stock, even without a major company catalyst. This guide breaks ...
A fresh cash bid for Two Harbors Investment Corp. sparks a renewed bidding war, putting pressure on UWM to top terms ...
Bakkt faces a pivotal year as crypto markets evolve and cash flow models mature. This guide explains what bakkt (bkkt...
A cautious retirement strategy uses an eight-rung treasury bond ladder to aim for about $40,000 a year in stable inco...
A high-stakes order from China could reshape Boeing’s revenue trajectory. Here’s how to think about the stock in 2026...
Mission Produce stock is rocketing as traders weigh earnings, margins, and guidance. Learn what drives the move, how ...
When an IPO plunges, investors face a tough choice. This guide explains how to evaluate a stock that is down 84% and ...
SpaceX is hinting at a bold new business path beyond rockets and Starlink. This article breaks down what spacex's sta...